The popularity of Sildenafil initially sparked a period of growth for the drug industry, nevertheless recent changes present a murky scenario for shareholders. Lower-cost alternatives are reducing revenue, and https://deannabbyx127879.blogacep.com/46804022/sildenafil-and-big-pharma-a-risky-investment